People · Operator

Jason Charles Heikenfeld

Named in public records as an officer, director or promoter · active 2016–2025 · Biotechnology

2
Companies
6
Filings
$14.8M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Eccrine Systems, Inc.BiotechnologySeries A$14.5M$67.5M2016
Kilele Health Inc.BiotechnologyPre-Seed$265K$569K2025
Operator network

Jason Charles Heikenfeld at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

John M. Rice · 2 companies · 1 sharedJohn M. RiceChad D. Clark · 1 companies · 1 sharedChad D. ClarkGavi D. Begtrup · 1 companies · 1 sharedGavi D. BegtrupJoseph E. Stigler · 1 companies · 1 sharedJoseph E. StiglerKara Fay Uchtman · 1 companies · 1 sharedKara Fay UchtmanKeith Charles Grimes · 1 companies · 1 sharedKeith Charles Gri…Mark D. Tierney · 1 companies · 1 sharedMark D. TierneyRichard D. Egan · 1 companies · 1 sharedRichard D. EganRobert Patterson Beech · 1 companies · 1 sharedRobert Patterson …Andrew David Cothrel · 1 companies · 1 sharedAndrew David Coth…Brittany Nicole Arde · 1 companies · 1 sharedBrittany Nicole A…Sven Charles Schreiber · 1 companies · 1 sharedSven Charles Schr…Eccrine Systems, Inc. · $14.5M raisedEccrine Systems, Inc.Kilele Health Inc. · $0.3M raisedKilele Health Inc.Jason Charles HeikenfeldJH
Jason Charles Heikenfeld Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jason Charles Heikenfeld on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
John M. Rice12
Mark D. Tierney11
Robert Patterson Beech11
Chad D. Clark11
Richard D. Egan11
Keith Charles Grimes11
Gavi D. Begtrup11
Sven Charles Schreiber11
Andrew David Cothrel11
Brittany Nicole Arde11
Kara Fay Uchtman11
Joseph E. Stigler11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.